CORCEPT THERAPEUTICS INC (1CORT.MI) Stock Balance Sheet
Europe • Euronext Milan • BIT:1CORT • US2183521028
38.02 EUR
-24.68 (-39.36%)
Last: Jan 26, 2026, 07:00 PM
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 89.82M | 127.67M | 135.55M | 66.30M | 77.60M | |||
| Marketable Securities | 234.76M | 257.49M | 232.67M | 365.30M | 145.90M | |||
| Receivables | 61.82M | 53.98M | 41.12M | 31.10M | 27.60M | |||
| Inventories | 14.37M | 12.41M | 7.73M | 6.10M | 5.00M | |||
| Other Current Assets | 37.74M | 20.06M | 41.56M | 30.40M | 10.30M | |||
| Total Current Assets | 438.50M | 471.60M | 458.64M | 499.30M | 266.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.69M | 8.01M | 315.00K | 1.80M | 1.50M | |||
| Investments And Advances | 248.04M | 219.83M | 57.18M | 4.90M | 112.30M | |||
| Other Non-Current Assets | 152.22M | 141.11M | 105.39M | 77.50M | 43.50M | |||
| Total Non-Current Assets | 407.95M | 368.95M | 162.88M | 84.10M | 157.30M | |||
| TOTAL ASSETS | 846.46M | 840.55M | 621.52M | 583.40M | 423.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 115.12M | 125.21M | 85.30M | 60.40M | 40.10M | |||
| Accounts Payable | 27.95M | 15.38M | 17.40M | 12.00M | 6.90M | |||
| Other Current Liabilities | N/A | 191.00K | 1.81M | 100.00K | 500.00K | |||
| Total Current Liabilities | 143.07M | 140.77M | 104.50M | 72.50M | 47.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 20.10M | 20.19M | 10.31M | 9.10M | 400.00K | |||
| Total Non-Current Liabilities | 20.10M | 20.19M | 10.31M | 9.10M | 500.00K | |||
| TOTAL LIABILITIES | 163.17M | 160.96M | 114.81M | 81.60M | 48.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 564.28M | 543.74M | 402.53M | 296.40M | 195.00M | |||
| Additional Paid In Capital | 862.87M | 832.11M | 738.51M | 662.30M | 591.30M | |||
| Common Shares | 137.00K | 136.00K | 133.00K | 100.00K | 100.00K | |||
| Treasury Stock | -744.69M | -696.17M | -635.08M | -456.10M | -410.40M | |||
| Other Shareholders' Equity | 692.00K | -217.00K | 609.00K | -900.00K | -200.00K | |||
| Shares Outstanding | 105.98M | 105.11M | 103.41M | 131.00M | 105.90M | |||
| Tangible Book Value per Share | 6.45 | 6.47 | 4.90 | 3.83 | 3.55 | |||
| Total Shareholders' Equity | 683.28M | 679.59M | 506.70M | 501.80M | 375.80M | |||
| TOTAL LIABILITIES AND EQUITY | 846.46M | 840.55M | 621.52M | 583.40M | 423.80M | |||
| Statistics | ||||||||
| Current Ratio | 3.07 | 3.35 | 4.39 | 6.89 | 5.61 | |||
| Return On Assets (ROA) | 15.83% | 16.80% | 17.08% | 17.38% | 26.55% | |||
| Return On Equity (ROE) | 19.61% | 20.78% | 20.95% | 20.21% | 29.94% | |||
| Return On Invested Capital (ROIC) | 13.61% | 16.89% | 17.91% | 19.03% | 28.56% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 25.27% | 37.58% | 62.24% | 122.58% | 70.34% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 25.27% | 37.58% | 62.24% | 122.58% | 70.34% | |||
All data in USD , ROIC based on taxRate of 0.14